Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Interleukin-8 (IL-8) and melanoma growth stimulating activity (MGSA) are CXC chemokines that activate neutrophils by binding to specific receptors.
• IL-8 binds both receptor-A and receptor-B with high affinity, while MGSA preferentially binds receptor-B over receptor-A.

Purpose of the Study:

• To investigate the structural basis of chemokine-receptor specificity between IL-8, MGSA, and their receptors.
• To design and characterize variants of IL-8 and MGSA with altered receptor binding properties.

Main Methods:

• Utilized known structures of IL-8 and MGSA to design chimeric variants.
• Performed loop swapping experiments between IL-8 and MGSA.
• Introduced additional mutations to modulate packing interactions and fine-tune binding.
• Investigated the effect of point mutations on receptor specificity.

Main Results:

• Swapping the loop from MGSA into IL-8 significantly reduced binding affinity for both receptors.
• An IL-8 variant with receptor-B specific binding was engineered through additional mutations.
• Swapping the loop from IL-8 into MGSA maintained receptor-B binding and only slightly reduced receptor-A affinity.
• Mutations in MGSA yielded a variant with high affinity for both receptors.
• Point mutations in IL-8 demonstrated that individual side chain substitutions can impact receptor specificity.

Conclusions:

• The loop preceding the first beta-strand is a critical determinant of IL-8 and MGSA binding specificity.
• Specific mutations can engineer chemokines with altered or novel receptor binding profiles.
• Understanding these structural determinants is key to deciphering chemokine function and designing targeted therapeutics.